Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Discovery of new therapeutic targets by the informational spectrum method.
Veljkovic N, Glisic S, Prljic J, Perovic V, Botta M, Veljkovic V. Veljkovic N, et al. Among authors: veljkovic v. Curr Protein Pept Sci. 2008 Oct;9(5):493-506. doi: 10.2174/138920308785915245. Curr Protein Pept Sci. 2008. PMID: 18855700 Review.
Identification of nanopeptide from HTLV-III, ARV-2 and LAVBRU envelope gp120 determining binding to T4 cell surface protein.
Veljković V, Metlas R. Veljković V, et al. Cancer Biochem Biophys. 1988 Nov;10(2):91-106. Cancer Biochem Biophys. 1988. PMID: 2855309
Potentially negative effects of AIDS vaccines based on recombinant viruses carrying HIV-1 derived envelope gene. A warning on AIDS vaccine development.
Veljkovic V, Metlas R. Veljkovic V, et al. Vaccine. 1993;11(3):291-2. doi: 10.1016/0264-410x(93)90189-5. Vaccine. 1993. PMID: 8447156
AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy.
Veljkovic V, Metlas R, Köhler H, Urnovitz HB, Prljic J, Veljkovic N, Johnson E, Müller S. Veljkovic V, et al. Among authors: veljkovic n. Vaccine. 2001 Feb 28;19(15-16):1855-62. doi: 10.1016/s0264-410x(00)00194-8. Vaccine. 2001. PMID: 11228354 Review.
Design of peptide mimetics of HIV-1 gp120 for prevention and therapy of HIV disease.
Veljkovic N, Branch DR, Metlas R, Prljic J, Vlahovicek K, Pongor S, Veljkovic V. Veljkovic N, et al. Among authors: veljkovic v. J Pept Res. 2003 Oct;62(4):158-66. doi: 10.1034/j.1399-3011.2003.00081.x. J Pept Res. 2003. PMID: 12969195
Molecular makeup of HIV-1 envelope protein.
Veljkovic V, Veljkovic N, Metlas R. Veljkovic V, et al. Among authors: veljkovic n. Int Rev Immunol. 2004 Sep-Dec;23(5-6):383-411. doi: 10.1080/08830180490432749. Int Rev Immunol. 2004. PMID: 15370272 Review.
Recombination property of the HIV-1 gp120 gene.
Prljic J, Veljkovic N, Veljkovic V. Prljic J, et al. Among authors: veljkovic n, veljkovic v. Int Rev Immunol. 2004 Sep-Dec;23(5-6):447-54. doi: 10.1080/08830180490432839. Int Rev Immunol. 2004. PMID: 15370276 Review.
Antibodies reactive with C-terminus of the second conserved region of HIV-1gp120 as possible prognostic marker and therapeutic agent for HIV disease.
Veljkovic N, Branch DR, Metlas R, Prljic J, Manfredi R, Stringer WW, Veljkovic V. Veljkovic N, et al. Among authors: veljkovic v. J Clin Virol. 2004 Dec;31 Suppl 1:S39-44. doi: 10.1016/j.jcv.2004.09.012. J Clin Virol. 2004. PMID: 15567092
Simple criterion for selection of flavonoid compounds with anti-HIV activity.
Veljkovic V, Mouscadet JF, Veljkovic N, Glisic S, Debyser Z. Veljkovic V, et al. Among authors: veljkovic n. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1226-32. doi: 10.1016/j.bmcl.2006.12.029. Epub 2006 Dec 12. Bioorg Med Chem Lett. 2007. PMID: 17189684
Anti-IgG antibodies from sera of healthy individuals neutralize HIV-1 primary isolates.
Metlas R, Srdic T, Veljkovic V. Metlas R, et al. Among authors: veljkovic v. Curr HIV Res. 2007 Mar;5(2):261-5. doi: 10.2174/157016207780077093. Curr HIV Res. 2007. PMID: 17346139
109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback